Ophthalmics

Type: Keyphrase

Name: Ophthalmics

First reported May 13 2013 - Updated May 13 2013 - 1 reports

May 2013 Editor's Picks: Products from Romaco and L.B. Bohle

Equipment and Processing ReportFeatured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing ReportRomacoFeatured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing ReportFilling machines ... [Published Pharmaceutical Technology - May 13 2013]

Entities: Liquidation, Ophthalmics, Membrane

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Santen to launch on May 13 of Sante Beaut$ye, a new OTC eye drop

Santen to launch on May 13 of Sante Beautéye, a new OTC eye dropDeveloped specifically to combat aging, enhance metabolism and reduce fatigueA package and container created by appeal to women by industrial designer Tokujin YoshiokaCelebrity Aya Sugimoto ... [Published Noodls - May 09 2013]

Entities: chondroitin sulfate, Sodium, Taurine, Contact Lens, Vitamin B12

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Dainippon Sumitomo Pharma Co Ltd

Ophthalmics Partnering Terms & Agreements

(M2 PRESSWIRE via COMTEX News Network) -- Research and Markets (http://www.researchandmarkets.com/research/343n2l/ophthalmics) has announced the addition of the " " report to their offering. The Opthalmics Partnering Terms and Agreements report provides ... [Published PredictWallStreet - May 08 2013]

Entities: Ophthalmics, Dainippon Sumitomo Pharma Co Ltd, Les Laboratoires SERVIER, Takeda Pharmaceutical Co Ltd

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Allegro Ophthalmics and Senju Pharmaceutical Ink Collaboration Deal

Allegro Ophthalmics and Senju Pharmaceutical Co announced that they have entered into a collaboration and license agreement to develop and market Allegro's Integrin Peptide Therapy in Japan. According to a release, with this collaboration, Allegro and ... [Published Individual.com - May 08 2013]

Entities: Ophthalmics, Peptide, Diabetic Macular Edema, collaboration, Japan

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Novartis AG

Shares of NVS Up 18.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Novartis (NYSE:NVS) on November 29th, 2012 at $61.98. In approximately 5 months, Novartis has returned 18.34% as of today's recent price of $73.34.In the past 52 weeks, shares of Novartis have traded between a low of ... [Published Comtex SmarTrend - May 07 2013]

Entities: Novartis AG, Stocks, Ophthalmics

First reported May 02 2013 - Updated May 03 2013 - 4 reports

Allegro, Senju sign licensing deal to develop integrin peptide therapy against vascular eye diseases

Allegro Ophthalmics and Senju Pharmaceutical have signed a collaboration and license deal for the development and commercialization of integrin peptide therapy as first in-class treatment of vascular eye diseases including wet age-related macular degeneration ... [Published PBR - News - May 03 2013]

Entities: Peptide, Ophthalmics, Wet Age-related Macular Degeneration, Diabetic Macular Edema

First reported May 02 2013 - Updated May 02 2013 - 1 reports

GKB Ophthalmics board to consider dividend

GKB Ophthalmics has informed BSE that a meeting of the Board of Directors of the Company will be held on May 24, 2013, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2013 and to recommend dividend, if ... [Published Moneycontrol.com - May 02 2013]

Entities: Ophthalmics, Dividend

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Lilly tops the poll for best sales reps

Lilly has come first in the industry’s biggest customer satisfaction survey for best medical sales representatives, jumping from third place last year, and shunting Pfizer into second place, while AstraZeneca moved to third place from last year’s position ... [Published Pharma Times - May 02 2013]

Entities: Medical Devices, NHS, Ophthalmics

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Shares of Novartis Rise Above Previous 52-Week High

Novartis (NYSE:NVS) traded today at a new 52-week high of $74.27. This new high was reached on below average trading volume as 1.1 million shares traded hands, while the average 30-day volume is approximately 1.6 million shares.Over the past year, Novartis ... [Published Scottrade - Apr 30 2013]

Entities: Novartis AG, Moving Average, Ophthalmics

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Martindale Pharma Appoints AAH , Sangers and TPS Healthcare as Wholesaler Partners for Distribution of Hospital Products

: Martindale Pharma, a leading international speciality pharmaceuticals company, today announced a change to distribution of its product portfolio to UK hospitals with the appointment of AAH, Sangers and TPS Healthcare as wholesale distributors.With effect ... [Published BioSpace - Apr 30 2013]

Entities: Wholesaler, NHS, Health Care

First reported Apr 16 2013 - Updated Apr 16 2013 - 1 reports

Biomedical Materials - Issue 3, 2013

A monthly news alert which addresses all the latest developments in ceramics, composites, metals, polymers and textiles for biomedical use including advances in materials, product launches and trials, industry news, international regulatory issues and ... [Published Research and Markets - Apr 16 2013]

Entities: Alerting Service, Pericardium, Ophthalmics, Aesculap, Cyberonics Inc

First reported Apr 16 2013 - Updated Apr 16 2013 - 1 reports

Novartis Shares Up 18.7% Since SmarTrend's Buy Recommendation (NVS)

SmarTrend identified an Uptrend for Novartis (NYSE:NVS) on November 29th, 2012 at $61.98. In approximately 5 months, Novartis has returned 18.74% as of today's recent price of $73.59.In the past 52 weeks, shares of Novartis have traded between a low of ... [Published Comtex SmarTrend - Apr 16 2013]

Entities: Novartis AG, Stocks, Ophthalmics

Quotes

...Corporation will complete a share consolidation of its common shares on a one for five basis (the "Consolidation") and a corporate name change to "Hemostemix Ltd. or such other name as TVI and the Corporation may determine (the "Name Change")."

Technical Ventures Announces Qualifying Transaction [Published Wolverton Securities - May 14 2013]

"Production and process efficiency are keywords that we now hear from our customers" says Heap, "with a greater

All-round advantage [Published Packaging Today - May 08 2013]

...artnership with one of the leading ophthalmic pharmaceutical companies in Japan," said Marc Kirshbaum, Chief Operating Officer, Allegro Ophthalmics. "In addition to validating the potential of Integrin Peptide Therapy as an additional treatment option for millions of patients at risk of blindness, this partnership provides Allegro with the capital required to significantly progress its clinical program across multiple indications and phases in the United States."

Allegro Ophthalmics and Senju Pharmaceutical Ink Collaboration Deal [Published Individual.com - May 08 2013]

..."We are extremely excited to be enhancing our CLAS-2D product line with these advanced capabilities", said President John Hart. "The integration of the wavefront products into Lumetrics has been extremely smooth and our core optical design strengths are critical to enhancing our customers capabilities."

Lumetrics, Inc. Develops New Line of Beam Expanders and Reducers to Enhance Wavefront Systems [Published Scottrade - Apr 15 2013]

More Content

sort by: Date \| Relevance
Voluntary Standards Cover the Spectrum: from La... [Published American National Standards Institute - 2 hours ago]
bitop AG and Alfa Intes signed License and Supp... [Published Open PR - 22 hours ago]
Sandoz US Announces Voluntary Nationwide Recall... [Published U.S. Food and Drug Administration - May 20 2013]
Preventing Reverse Pupillary Block [Published CRS Today - May 17 2013]
Allegro, Senju collaborate on integrin peptide ... [Published Ophthalmology Times - May 15 2013]
Hi-Tech Pharmacal's Management Presents at Bank... [Published Seeking Alpha - May 15 2013]
Technical Ventures Announces Qualifying Transac... [Published Wolverton Securities - May 14 2013]
May 2013 Editor's Picks: Products from Romaco a... [Published Pharmaceutical Technology - May 13 2013]
Phase Focus Limited - Medical Equipment - Deals... [Published TransWorldNews - May 13 2013]
Santen to launch on May 13 of Sante Beaut$ye, a... [Published Noodls - May 09 2013]
Research and Markets: Ophthalmics Partnering Te... [Published Business Wire Professional Services News - May 08 2013]
Research and Markets: Ophthalmics Partnering Te... [Published Business Wire Health News - May 08 2013]
Ophthalmics Partnering Terms & Agreements [Published PredictWallStreet - May 08 2013]
All-round advantage [Published Packaging Today - May 08 2013]
Allegro Ophthalmics and Senju Pharmaceutical In... [Published Individual.com - May 08 2013]
Shares of NVS Up 18.3% Since Uptrend Call on Sh... [Published Comtex SmarTrend - May 07 2013]
Perrigo Management Discusses Q3 2013 Results - ... [Published Seeking Alpha - May 07 2013]
Akorn's CEO Discusses Q1 2013 Results - Earning... [Published Seeking Alpha - May 07 2013]
Allegro Ophthalmicsと千寿製薬、血管性眼疾患に対する画期的新薬としてのインテ... [Published Business Wire Health News - May 06 2013]
Lumetrics, Inc. Develops New Line Of Beam Expan... [Published Metrology World .com - May 03 2013]
Allegro, Senju sign licensing deal to develop i... [Published PBR - News - May 03 2013]
Allegro Ophthalmics signs collaboration and lic... [Published Zecco - May 02 2013]
GKB Ophthalmics board to consider dividend [Published Moneycontrol.com - May 02 2013]
Lilly tops the poll for best sales reps [Published Pharma Times - May 02 2013]
Allegro Ophthalmics and Senju Pharmaceutical An... [Published BioMedReports - May 02 2013]
Allegro Ophthalmics and Senju Pharmaceutical An... [Published NewsBlaze - May 02 2013]
Allegro Ophthalmics and Senju Pharmaceutical An... [Published Business Wire Health News - May 02 2013]
Shares of Novartis Rise Above Previous 52-Week ... [Published Scottrade - Apr 30 2013]
Martindale Pharma Appoints AAH , Sangers and TP... [Published BioSpace - Apr 30 2013]
Visually Significant Traumatic Cataract [Published Cataract & Refractive Surgery Today - Apr 21 2013]

Blogs

sort by: Date \| Relevance
Allegro, Senju sign licensing deal to develop i... [Published PBR - News - May 03 2013] Allegro Ophthalmics and Senju Pharmaceutical have signed a collaboration and license deal for the development and commercialization of integrin peptide therapy as first in-class treatment of vascular eye diseases including wet age-related macular degeneration ...
Up And Down The Ladder… Job Changes [Published Pharmalot - Mar 01 2013] Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants ...

Press Releases

sort by: Date \| Relevance
Research and Markets: Ophthalmics Partnering Te... [Published Business Wire Professional Services News - May 08 2013]
Research and Markets: Ophthalmics Partnering Te... [Published Business Wire Health News - May 08 2013]
Allegro Ophthalmicsと千寿製薬、血管性眼疾患に対する画期的新薬としてのインテ... [Published Business Wire Health News - May 06 2013]
Allegro Ophthalmics and Senju Pharmaceutical An... [Published Business Wire Health News - May 02 2013]
Research and Markets: Ophthalmics Partnering Ye... [Published Business Wire Health News - Feb 06 2013]